Interstitial Cystitis/Painful Bladder Syndrome

IC/BPS Overview - Bladder's Cry

• Chronic pelvic pain, pressure, or discomfort perceived to be related to the urinary bladder.
• Associated with ≥1 urinary symptom (e.g., urgency, frequency).
• More common in women (9:1 ratio vs men).
• Etiology: Unknown; ?urothelial dysfunction, mast cell activation, neurogenic inflammation.
• Diagnosis of exclusion.

⭐ AUA definition: unpleasant sensation (pain, pressure, discomfort) perceived to be related to the urinary bladder, associated with lower urinary tract symptoms of more than 6 weeks duration, in the absence of infection or other identifiable causes.

• 📌 Mnemonic: Inflamed Cystitis Bothers Patients Severely (IC/BPS).

Pathophysiology - The Bladder Barrier Breach

• Primary defect: Urothelial barrier dysfunction.
  • Impaired integrity of the bladder lining.
  • Allows noxious urine components to penetrate.
• Key mechanism:
  • Increased permeability of the urothelium.
  • Potassium ($K^+$) ions and other solutes leak into the submucosa.
• Resultant inflammation & sensitization:
  • Mast cell activation, releasing histamine & cytokines.
  • Neurogenic inflammation and C-fiber sensitization.
  • Leads to chronic pain, urgency, and frequency.

⭐ Defective urothelial glycosaminoglycan (GAG) layer is a key theory, leading to increased bladder permeability and solute leakage into the interstitium.

Clinical Features - Symptom Spotlight

• Pain:
  • Chronic (>6 weeks), pelvic; locations: suprapubic, perineal, urethral.
  • Character: pressure, discomfort, or intense.

  ⭐ The hallmark symptom is pain related to bladder filling, often suprapubic or pelvic, which is typically relieved by voiding.

• Urinary Symptoms:
  • Frequency (often >8/day), urgency (often compelling).
  • Nocturia (often >2/night).
• Associated:
  • Dyspareunia (common).
  • Worsened by specific dietary triggers (e.g., acidic, spicy).
  • Diagnosis of exclusion (no infection/other pathology).

Diagnosis Decoded - Pinpointing the Pain

IC/BPS is primarily a diagnosis of exclusion.

• Core Symptoms:
  • Chronic pelvic pain, pressure, or discomfort >6 weeks, perceived to be bladder-related.
  • Accompanied by urinary urgency or frequency.
• Exclusion is Key:
  • Rule out: Infection (negative urine culture), bladder stones, malignancy, endometriosis, other urologic/gynecologic causes.
• Key Investigations:
  • Urinalysis & culture: Mandatory.
  • Cystoscopy with hydrodistention:
    • Reveals glomerulations (petechial hemorrhages).
    • Identifies Hunner's lesions.

  ⭐ Hunner's lesions, seen in about 5-10% of patients on cystoscopy with hydrodistention, are specific for IC/BPS and appear as distinct, inflamed, often bleeding areas.

  • Biopsy: If Hunner's lesions or suspicious findings.

Management Matrix - Alleviating Agony

• Conservative & Behavioral:
  • Diet modification (avoid triggers: caffeine, alcohol, acidic foods)
  • Bladder training, stress management
  • Pelvic floor physical therapy
• Oral Medications:
  • Amitriptyline (TCA)
  • Hydroxyzine (antihistamine)
  • Pentosan polysulfate sodium (PPS)

  ⭐ Pentosan polysulfate sodium (PPS) is the only FDA-approved oral medication specifically for IC/BPS, thought to replenish the GAG layer.

• Intravesical Instillations:
  • Dimethyl sulfoxide (DMSO)
  • Heparin, Lidocaine
• Interventional/Surgical (Refractory):
  • Hydrodistension
  • Botulinum toxin A injection
  • Sacral neuromodulation
  • Urinary diversion/cystectomy (rare)

High‑Yield Points - ⚡ Biggest Takeaways

• Chronic pelvic pain, pressure, or discomfort related to the bladder, lasting > 6 weeks.
• Often accompanied by urinary frequency, urgency, and nocturia.
• A diagnosis of exclusion; rule out infection and other pathologies.
• Cystoscopy may reveal Hunner's ulcers (classic IC) or glomerulations.
• Pain on bladder filling, relieved by voiding, is characteristic.
• Multimodal management: diet, bladder training, amitriptyline, pentosan polysulfate, intravesical therapy.
• Negative urine culture is essential for diagnosis.